These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate]. Berliner J Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024 [No Abstract] [Full Text] [Related]
7. [Results of the use of fluphenazine in a depot preparation]. Marcjan K; Pietruszewska I; Wolak E Psychiatr Neurol Med Psychol Beih; 1975; 20-21():176-82. PubMed ID: 829619 [TBL] [Abstract][Full Text] [Related]
8. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients. Gaby N; Lefkowitz D; Israel JR N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987 [No Abstract] [Full Text] [Related]
9. [Treatment of schizophrenic psychoses with Lyorodin]. Schulz HD; Kluge HH; Korda W; Kube B Psychiatr Neurol Med Psychol (Leipz); 1977 Jun; 29(6):360-6. PubMed ID: 918199 [TBL] [Abstract][Full Text] [Related]
10. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia. Horodnicki JM; Czekalski S; Jarema M Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002 [No Abstract] [Full Text] [Related]
11. A clinical guide for diagnosing and managing patients with drug-induced dysphagia. Weiden P; Harrigan M Hosp Community Psychiatry; 1986 Apr; 37(4):396-8. PubMed ID: 3699706 [No Abstract] [Full Text] [Related]
12. Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam. Kontaxakis VP; Christodoulou GN; Markidis MP; Havaki-Kontaxaki BJ Acta Psychiatr Scand; 1988 Sep; 78(3):396-8. PubMed ID: 3195360 [TBL] [Abstract][Full Text] [Related]
13. "Clubbing" -- a side-effect of long-term phenothiazines treatment. Halbreich U; Assael M Confin Psychiatr; 1976; 19(2):96-8. PubMed ID: 828569 [TBL] [Abstract][Full Text] [Related]
14. [Is there a special indication for fluphenazine in therapy refractory hallucinations?]. Bechter K Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159 [TBL] [Abstract][Full Text] [Related]
15. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome. Liu PY; Wu PC; Chen CY; Chen YC Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143 [TBL] [Abstract][Full Text] [Related]
16. Fluphenazine enanthate for the difficult psychotic patient. Stewart AR; Lavallee B Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574 [No Abstract] [Full Text] [Related]
17. High vs standard dosage fluphenazine HCL in acute schizophrenia. Donlon PT; Meadow A; Tupin JP; Wahba M J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702 [TBL] [Abstract][Full Text] [Related]
18. Psychiatric pharmacotherapy and the schizophrenic defect. Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088 [No Abstract] [Full Text] [Related]
19. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia. MacCrimmon DJ; Saxena B; Foley P; Grof P Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838 [TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with fluphenazine Depot]. Vencovský E; Sedivec V; Peterová E; Baudis P; Dvoráková M Act Nerv Super (Praha); 1970 Jan; 12(1):49-50. PubMed ID: 5418656 [No Abstract] [Full Text] [Related] [Next] [New Search]